CEL-SCI’s LEAPS Peptides Demonstrate Clear Survival Benefit as a Treatment for COVID-19 in Preclinical Studies
Rankings by 
Национальный рейтинг
210th
in United StatesРегиональный рейтинг
230th
in North America and CaribbeanГлобальный рейтинг
577th
worldwide